Regulatory Documents For Clinical Research Sites Webinar

Подписаться 35 тыс.

Просмотров 20 тыс.

50% 1

Regulatory Documents For Clinical Research Sites Webinar
www.TheClinicalTrialsGuru.com
Site Owner Academy: www.theclinicaltrialsguru.com/...
My CRO: www.DSCScro.com
My CRA Academy: www.TheCRAacademy.com
My Research News Site: www.TheClinicalScoop.com
Call/Text: (949) 415-6256
Follow Me On:
SnapChat: username is dansfera
Instagram: / dansfera
Twitter: / therealdansfera
Facebook: / dansfera
LinkedIn: / view. .
My iTunes Podcast: itunes.apple.com/us/podcast/r...
My Stitcher Podcast: www.stitcher.com/podcast/dan-s...
Google Play Podcast: playmusic.app.goo.gl/?ibi=com...

Опубликовано:

25 июл 2018

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист

Посмотреть позже

Комментарии : 26

@solomonjunior377 2 года назад

The best cllinical research webinar on regulatory requirements for SSU that I've seen. Thank you!

@susanromano5705 3 года назад

Awesome! Thanks

@aneta5106 Год назад

Great webinar! A lot of useful knowledge with the eye of practitioner.

@2minuteschool929 3 года назад

some serious stuff..goodnight

@BucurEST1989 2 года назад

Nice job guys

@dansfera 2 года назад

thank you!

@2minuteschool929 3 года назад

Chris had a point behind the kidding statement, log makes sense,but P.I should act sensibly and be knowledgeable, of course for the benefit of the patients without co intervention/ deviation from protocol😇

@priyakiran8506 2 года назад

Please help me to understand initial crucial documents require to start study

@charme2377 3 года назад

thank you dan for the excllent video , is study start up just in phase 1 or all single phase we do same steps and documents ?

@dansfera 3 года назад

Any study

@user-vy9me1un5x 11 месяцев назад

awesome as always, am so lucky to have found this webinar. First and foremost can you be kind enough to share these slides? Secondly, in relation to the financial disclosure slide, if there is no IP hence no pharmaceutical company, do we forego this disclosure since it says ..."no financial interest in the pharmaceutical company conducting the study" ? or is the sentence then just modified to the type of study? i hope I am making sense, I am from Zambia English is not native and am new to research at this level, just left clinical practice. Thanks

@2minuteschool929 3 года назад

Basic things in the forms on all countries are the same.

@user-vy9me1un5x 11 месяцев назад

concerning IRB approval, even if the site has no ongoing study in that particular year should they still have a yearly renewed approval or this is done just with receipt of a study?

@njidekaangelica5778 Год назад

Thanks for this webinar, it is very informative. please where can I get GCP training certification...which institution/site offers the certification training?? Thank you..

@user-vy9me1un5x 11 месяцев назад

concerning credentials, as we file renewed licenses, how far back can we continue to keep expired licenses on file or can we discard?

@Walwatf 2 года назад

I have a bs in science 2012 , i also have phlebotomist certification, i want get in field, what more certification or skills i need to get in field

@dansfera 2 года назад

just start at a research clinic near you

@priyakiran8506 2 года назад

Difference between SUSARA and CIOMA?

@dansfera 2 года назад

Dont know what cioma is

@charmaineowusu3637 Год назад

Is this applicable for the uk

@dansfera Год назад

Yes

@gadeboye2001 4 года назад

Do all subjects start on same date.....for example for a Phase 2 trial of may be 10 to 20 Subjects .....are they all starting same day upon Site Initiation

@dansfera 4 года назад

No. Subjects can start whenever they can. Sites cannot screen any until after siv. Know the difference between enrollment window and study duration

@gadeboye2001 4 года назад

@@dansfera just saw this clip.....www.theclinicaltrialsguru.com/blog1/enrollment-window-vs-study-length-in-clinical-trials